Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001639691-17-000045
Filing Date
2017-05-15
Accepted
2017-05-15 14:55:55
Documents
10
Period of Report
2017-06-14
Effectiveness Date
2017-05-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14ahtm.htm DEF 14A 1006972
2 cmesignaturea02.jpg GRAPHIC 8874
3 cmesignaturea03.jpg GRAPHIC 8874
4 livanovadef14aimage1a01.jpg GRAPHIC 21386
5 livanovadef14aimage2a01.jpg GRAPHIC 4587
6 livanovadef14aimage3a01.jpg GRAPHIC 20461
7 livanovadef14aimage5a01.jpg GRAPHIC 20476
8 livanovadef14aimage6a01.jpg GRAPHIC 172255
9 livanovaplcbc6001a01.jpg GRAPHIC 129308
10 livanovaplcbc6002a01.jpg GRAPHIC 156372
  Complete submission text file 0001639691-17-000045.txt   1756744
Mailing Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG
Business Address 20 EASTBOURNE TERRACE LONDON X0 W2 6LG 4402033250662
LivaNova PLC (Filer) CIK: 0001639691 (see all company filings)

EIN.: 981268150 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37599 | Film No.: 17843546
SIC: 3845 Electromedical & Electrotherapeutic Apparatus